Works matching IS 00281298 AND DT 2019 AND VI 392 AND IP 12

Results: 13

Growth inhibitor of human hepatic carcinoma HepG2 cells by evodiamine is associated with downregulation of PRAME.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, v. 392, n. 12, p. 1551, doi. 10.1007/s00210-019-01701-7

By:

Zhu, Hanzhang;
Ge, Ke;
Lu, Jun;
Jia, Changku

Publication type:

Article

Telmisartan attenuates N-nitrosodiethylamine-induced hepatocellular carcinoma in mice by modulating the NF-κB-TAK1-ERK1/2 axis in the context of PPARγ agonistic activity.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, v. 392, n. 12, p. 1591, doi. 10.1007/s00210-019-01706-2

By:

Saber, Sameh;
Khodir, Ahmed E.;
Soliman, Wafaa E.;
Salama, Mohamed M.;
Abdo, Walied S.;
Elsaeed, Baraah;
Nader, Karim;
Abdelnasser, Aya;
Megahed, Nada;
Basuony, Mohamed;
Shawky, Ahmed;
Mahmoud, Maryam;
Medhat, Reham;
Eldin, Abdelrahman S.

Publication type:

Article

Chrysin ameliorates nonalcoholic fatty liver disease in rats.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, v. 392, n. 12, p. 1617, doi. 10.1007/s00210-019-01705-3

By:

Pai, Sarayu A.;
Munshi, Renuka P.;
Panchal, Falguni H.;
Gaur, Ila-Shruti;
Juvekar, Archana R.

Publication type:

Article

The dual PPAR-α/γ agonist saroglitazar ameliorates thioacetamide-induced liver fibrosis in rats through regulating leptin.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, v. 392, n. 12, p. 1569, doi. 10.1007/s00210-019-01703-5

By:

Makled, Mirhan N.;
Sharawy, Maha H.;
El-Awady, Mohammed S.

Publication type:

Article

Promising role of filgrastim and α-tocopherol succinate in amelioration of gastrointestinal acute radiation syndrome (GI-ARS) in mice.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, v. 392, n. 12, p. 1537, doi. 10.1007/s00210-019-01702-6

By:

Gheita, Heba A.;
El-Sabbagh, Walaa A.;
Abdelsalam, Rania M.;
Attia, Amina S.;
El-Ghazaly, Mona A.

Publication type:

Article

Effects of diosmin and crocin on metabolic syndrome-associated cardio-vascular complications in rats.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, v. 392, n. 12, p. 1523, doi. 10.1007/s00210-019-01700-8

By:

El-Fawal, Rania;
El Fayoumi, Hassan M.;
Mahmoud, Mona F.

Publication type:

Article

Gastroprotective effect of cilostazol against ethanol- and pylorus ligation–induced gastric lesions in rats.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, v. 392, n. 12, p. 1605, doi. 10.1007/s00210-019-01699-y

By:

Moawad, Helmy;
El Awdan, Sally A.;
Sallam, Nada A.;
El-Eraky, Wafaa I;
Alkhawlani, Mohammed A.

Publication type:

Article

Effects of fast versus slow-releasing hydrogen sulfide donors in hypertension in pregnancy and fetoplacental growth restriction.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, v. 392, n. 12, p. 1561, doi. 10.1007/s00210-019-01697-0

By:

Zochio, Gabriela Palma;
Possomato-Vieira, Jose Sergio;
Chimini, Jessica Sabbatine;
da Silva, Maria Luiza Santos;
Dias-Junior, Carlos Alan

Publication type:

Article

Therapeutic effects of resveratrol in Escherichia coli-induced rat endometritis model.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, v. 392, n. 12, p. 1577, doi. 10.1007/s00210-019-01696-1

By:

Demirel, Murside Ayse;
Han, Sevtap;
Tokmak, Aytekin;
Ercan Gokay, Nilufer;
Uludag, Mecit Orhan;
Yildirir Ustun, Tugçe;
Cicek, Ali Fuat

Publication type:

Article

Agonists activate different A<sub>2B</sub> adenosine receptor signaling pathways in MBA-MD-231 breast cancer cells with distinct potencies.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, v. 392, n. 12, p. 1515, doi. 10.1007/s00210-019-01695-2

By:

Koussémou, Marthe;
Klotz, Karl-Norbert

Publication type:

Article

Liver damage in bleomycin-induced pulmonary fibrosis in mice.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, v. 392, n. 12, p. 1503, doi. 10.1007/s00210-019-01690-7

By:

Vásquez-Garzón, V. R.;
Ramírez-Cosmes, A.;
Reyes-Jiménez, E.;
Carrasco-Torres, G.;
Hernández-García, S.;
Aguilar-Ruiz, S. R.;
Torres-Aguilar, H.;
Alpuche, J.;
Pérez-Campos Mayoral, L.;
Pina-Canseco, S.;
Arellanes-Robledo, J.;
Villa-Treviño, S.;
Baltiérrez-Hoyos, R.

Publication type:

Article

Stylosin and some of its synthetic derivatives induce apoptosis in prostate cancer cells as 15-lipoxygenase enzyme inhibitors.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, v. 392, n. 12, p. 1491, doi. 10.1007/s00210-019-01689-0

By:

Goftari, Seyed Navid;
Sadeghian, Hamid;
Bahrami, Ahmad Reza;
Maleki, Fatemeh;
Matin, Maryam M.

Publication type:

Article

Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating PIM1.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, v. 392, n. 12, p. 1477, doi. 10.1007/s00210-019-01687-2

By:

Li, Qian;
Jiang, Chuanwu;
Wang, Yan;
Wei, Minghua;
Zheng, Huijin;
Xu, Yanqi;
Xu, Xuegang;
Jia, Fengyu;
Liu, Kai;
Sun, Gang;
Zang, Jianhua;
Mo, Ping

Publication type:

Article